TrialThrombosis and haemostasis2025

Final Analysis Results from the AGEHA Study: Emicizumab Prophylaxis for Acquired Hemophilia A with or without Immunosuppressive Therapy.

Midori Shima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.